A 49-year-old woman developed eosinophilic peritonitis 2 months after starting continuous ambulatory peritoneal dialysis because of congenital right kidney hypoplasia and chronic glomerulonephritis. This was shown to have been induced by sucroferric oxyhydroxide, an iron-based phosphate binder, using a drug-induced lymphocyte stimulation test. Her eosinophilic peritonitis was improved after stopping the administration of sucroferric oxyhydroxide without providing any immunosuppressive agents.
ChanMKChowLLamSS, et al.Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis1988; 11: 180–183.
2.
FontánMPRodríguez-CarmonaAGaledI, et al.Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis. Perit Dial Int2003; 23: 460–464.
3.
QuinlanCCantwellMReesL. Eosinophilic peritonitis in children on chronic peritoneal dialysis. Pediatr Nephrol2010; 25: 517–522.
4.
ShigemotoEMizunoMSuzukiY, et al.Increase of eosinophil in dialysate during induction of peritoneal dialysis. Perit Dial Int2019; 39: 90–92.
5.
ChenYLiZMoL, et al.Eosinophilia in peritoneal effluent due to a levonorgestrel-releasing intrauterine system in a woman on peritoneal dialysis. Perit Dial Int2017; 37: 349–350.
6.
DeweeseRSlavensJBaruaA, et al.Vancomycin-induced eosinophilic peritonitis. Am J Health Syst Pharm2016; 73: e243–e246.
